Invasive aspergillosis caused by Aspergillus terreus in a living donor liver transplant recipient successfully treated by caspofungin.
Invasive aspergillosis is one of the most severe complications after liver transplantation characterised by early dissemination of disease and high mortality. Recent data show that the prognosis is diminishing even further when Aspergillus terreus, a strain resistant to standard treatment with amphotericin, is isolated. We report a high risk liver transplant recipient with multiple co-morbidities including renal failure and allograft dysfunction in whom pulmonary aspergillosis due to A. terreus was successfully treated by the echinocandin antifungal agent caspofungin.
Walter
Jessica
J
Sobottka
Ingo
I
Rogiers
Xavier
X
Broering
Dieter
D
Fischer
Lutz
L
D000935:Antifungal Agents / Q000008:administration & dosage*; D001230:Aspergillus / Q000187:drug effects / Q000302:isolation & purification*; D000077336:Caspofungin; D054714:Echinocandins / Q000008:administration & dosage*; D006801:Humans; D016867:Immunocompromised Host; D055666:Lipopeptides; D016031:Liver Transplantation / Q000009:adverse effects; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D055732:Pulmonary Aspergillosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology; D014180:Transplantation; D016896:Treatment Outcome
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D000077336:Caspofungin